SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000914760-15-000279
Filing Date
2015-09-29
Accepted
2015-09-29 08:05:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEPTEMBER 18, 2015 akari_13d.htm SC 13D 84176
  Complete submission text file 0000914760-15-000279.txt   85920
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: SC 13D | Act: 34 | File No.: 005-87614 | Film No.: 151128889
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LANDMARK FIDUCIAIRE (SUISSE) SA 6 PLACE DES EAUX-VIVES, PO BOX 3461 GENEVA V8 1211
Business Address C/O LANDMARK FIDUCIAIRE (SUISSE) SA 6 PLACE DES EAUX-VIVES, PO BOX 3461 GENEVA V8 1211 44 (0)20 7025 7911
RPC Pharma Ltd (Filed by) CIK: 0001653315 (see all company filings)

IRS No.: 000000000 | State of Incorp.: IL
Type: SC 13D